Moffitt Cancer Center Seeks Prostate Cancer Patients and Caregivers for Unique Study

July 29, 2014

TAMPA, Fla. – Moffitt Cancer Center is recruiting patients and their caregivers for a research study that takes a closer look at the uptake of prostate cancer specific information and health services of men who are newly diagnosed and undergoing treatment for prostate cancer. Prostate cancer is the most commonly diagnosed cancer among men in the United States, but is highly treatable.

“This study looks specifically at addressing the educational and psychosocial needs of men recently diagnosed and undergoing treatment for prostate cancer as well as their caregivers,” said Brian Rivers, Ph.D., M.P.H., principal investigator of this study and assistant member of the Health Outcomes & Behavior Program at Moffitt.

Patients and caregivers in the study will receive comprehensive education materials about prostate cancer, as well as access to a community health navigator. During this time, participants will participate in a series of telephone interviews during various stages of the care process.

To enroll in the study, participants must be between 40 and 75 years old and have been diagnosed with prostate cancer in the past three months. Patients must also have a caregiver, who could be a family member, spouse, or friend, who is willing to participate.

Those interested in being part of the study should contact Shani V. Davis, Ph.D., ANP-BC, at or 813-745-6806.

About Moffitt Cancer Center
Located in Tampa, Moffitt is one of only 41 National Cancer Institute-designated Comprehensive Cancer Centers, a distinction that recognizes Moffitt’s excellence in research, its contributions to clinical trials, prevention and cancer control. Moffitt is the top-ranked cancer hospital in Southeast and has been listed as one of U.S. News & World Report’s “Best Hospitals” for cancer since 1999. With more than 4,500 employees, Moffitt has an economic impact on Florida of nearly $1.6 billion. For more information, visit, and follow the Moffitt momentum on Facebook, Twitter and YouTube.